Education
About Us
Working with TipRanks
Follow Us
Torii Pharmaceutical Co Ltd (TRXPF)
OTHER OTC:TRXPF
RESEARCH TOOLSreports
Total Valuation
Torii Pharmaceutical Co has a market cap or net worth of $1.20B. The enterprise value is $144.37B.
Market Cap$1.20B
Enterprise Value$144.37B
Share Statistics
Torii Pharmaceutical Co has 14 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding14
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Torii Pharmaceutical Co’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 4.16%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.16%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee102.07M
Profits Per Employee11.36M
Employee Count592
Asset Turnover0.43
Inventory Turnover2.37
Valuation Ratios
The current PE Ratio of Torii Pharmaceutical Co is 28.5. Torii Pharmaceutical Co’s PEG ratio is ―.
PE Ratio28.5
PS Ratio―
PB Ratio―
Price to Fair Value1.72M
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Torii Pharmaceutical Co had revenue of 60.42B and earned 5.04B in profits. Earnings per share was 179.46.
Revenue60.42B
Gross Profit26.71B
Operating Income6.80B
Pretax Income6.72B
Net Income5.04B
EBITDA7.13B
Earnings Per Share (EPS)179.46
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Torii Pharmaceutical Co pays an annual dividend of $0.382, resulting in a dividend yield of 0%
Dividend Per Share$0.382
Dividend Yield0%
Payout Ratio60.49%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change39.08%
50-Day Moving Average36.62
200-Day Moving Average33.62
Relative Strength Index (RSI)76.47
Average Volume (3m)0.00
Important Dates
Torii Pharmaceutical Co upcoming earnings date is Oct 30, 2025, TBA (Confirmed).
Last Earnings DateJul 31, 2025
Next Earnings DateOct 30, 2025
Ex-Dividend DateDec 31, 2024
Financial Position
Torii Pharmaceutical Co as a current ratio of 5.21, with Debt / Equity ratio of 0.00%
Current Ratio5.21
Quick Ratio4.43
Debt to Market Cap0.00
Net Debt to EBITDA-0.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Torii Pharmaceutical Co has paid 1.68B in taxes.
Income Tax1.68B
Effective Tax Rate0.25
Enterprise Valuation
Torii Pharmaceutical Co EV to EBITDA ratio is 29.32M, with an EV/FCF ratio of 60.46M.
EV to Sales3.46M
EV to EBITDA29.32M
EV to Free Cash Flow60.46M
EV to Operating Cash Flow57.47M
Balance Sheet
Torii Pharmaceutical Co has $40.74B in cash and marketable securities with $559.00M in debt, giving a net cash position of $40.74B billion.
Cash & Marketable Securities$40.74B
Total Debt$559.00M
Net Cash$40.74B
Net Cash Per Share$2.91B
Tangible Book Value Per Share$4.31K
Margins
Gross margin is 40.28%, with operating margin of 11.25%, and net profit margin of 8.34%.
Gross Margin40.28%
Operating Margin11.25%
Pretax Margin11.13%
Net Profit Margin8.34%
EBITDA Margin11.80%
EBIT Margin11.13%
Analyst Forecast
The average price target for Torii Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―